Paper

Controlled-release oxycodone versus placebo in the treatment of chronic breathlessness - a multi-site randomised placebo controlled trial.

Published Mar 1, 2020 · B. Fazekas, D. Ferreira, N. McCaffrey

Journal of pain and symptom management

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCT

Study Snapshot

There was no signal of benefit from oxycodone over placebo in reducing chronic breathlessness, and future research should focus on investigating an opioid class effect on breathlessness reduction.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Controlled-release oxycodone versus placebo in the treatment of chronic breathlessness - a multi-site randomised placebo controlled trial.

References

Citations